NCT07528833 Health Effects of Mindfulness Based Stress Reduction Course in Treatment of Back Pain
| NCT ID | NCT07528833 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tampere University Hospital |
| Condition | Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-01-01 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
* Health effects of mindfulness based stress reduction course versus usual care in treatment of back pain: a randomized clinical trial * Mindfulness based stress reduction (MBSR) course intervention for half of the research patients * MBSR course lasts for 8 weeks. * follow-up time 2 years. * research data is collected by Recdap * Working-age (18-64 years) patients with back pain in thoracal or lumbar area (NRS at least 4) with or without radiculation over 12 weeks will be recruited. * The primary outcome measure is Numeric pain rating scale (NRS, 0-10).
Eligibility Criteria
Inclusion Criteria: * Working-age (18-64 years) patients * Back pain in thoracal or lumbar area * NRS at least 4 * With or without radiculative symptoms * Pain duration over 12 weeks * Pain can be localized or widespread * Also patients with multiple pain are eligible * X-ray or MRI scan is not needed * Patients can be both gender * Finnish language skills and adequate competence are needed for filling the survey forms and participation in interventions Exclusion Criteria: * Pregnancy * Recent delivery (\<12 months) * Mental health problems with psychotic symptoms * Acute severe psychological trauma (3 months) * Sings of back infection * Acute severe trauma in the back (fracture) * surgery (\< 6 months) * planned surgery in the future * tumor in the back
Contact & Investigator
Jussi Repo, PhD, M.D. orthopedical surgeon
STUDY DIRECTOR
Tampere University Hospital
Frequently Asked Questions
Who can join the NCT07528833 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 64 Years, studying Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07528833 currently recruiting?
Yes, NCT07528833 is actively recruiting participants. Contact the research team at jennasisouno@gmail.com for enrollment information.
Where is the NCT07528833 trial being conducted?
This trial is being conducted at Tampere, Finland, Tampere, Finland, Tampere, Finland, Tampere, Finland.
Who is sponsoring the NCT07528833 clinical trial?
NCT07528833 is sponsored by Tampere University Hospital. The principal investigator is Jussi Repo, PhD, M.D. orthopedical surgeon at Tampere University Hospital. The trial plans to enroll 120 participants.